This excerpt taken from the EYE 8-K filed Aug 2, 2007.
Second-Quarter Performance by Product Line
Below are sales highlights of second-quarter 2007 results by product line. Growth rates reflect comparisons to the same period in 2006 and include the impacts of foreign currency. Pro forma growth rates reflect comparisons that include IntraLases performance in the same period of 2006. For more information, see the table entitled Global Sales that accompanies this release.
Cataract/Implant sales rose 4.3 percent to $140.2 million.
Laser Vision Correction (LVC) sales rose 91.2 percent to $102.1 million.
Eye Care sales declined 72.5 percent to $19.0 million.